Entirely in vivo enzyme evolution and engineering of Cre recombinase

Cre 重组酶的全体内酶进化和工程

• 批准号: 7751461
• 负责人: Dante William Romanini
• 金额: $ 4.72万
• 依托单位: COLUMBIA UNIV NEW YORK MORNINGSIDE
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7751461
• 关键词: Address; Artificial Organs; Biological Assay; Biological Models; Cells; Collection; Complex; DNA; Development; Effectiveness; Engineering; Enzymes; Evolution; Gene Targeting; Generations; Genes; Genetic; Goals; Health; In Vitro; Libraries; Methodology; Methods; Modeling; Mus; Mutagenesis; Mutation; Nonsense Mutation; Partner in relationship; Pathway interactions; Pharmaceutical Preparations; Pharmacologic Substance; Plasmids; Population; Procedures; Process; Property; Protein Engineering; Proteins; Protocols documentation; Reporting; Reproduction; Research; Saccharomyces cerevisiae; Saccharomycetales; Site; Specificity; Speed; Substrate Specificity; System; Techniques; Technology; Testing; Therapeutic; Variant; Virtual Library; Yeasts; base; daughter cell; directed evolution; endonuclease; homologous recombination; improved; in vivo; interest; mutant; novel; nuclease; pressure; public health relevance; recombinase; remediation; repaired; research study; success; trend

DESCRIPTION (provided by applicant): Directed evolution is a versatile method for the creation of proteins with novel properties. The evolution of enzymes has already provided variants with higher stability, increased efficiency, and altered specificity or enantioselectivity. As the trend of using enzymes in industrial processes, the synthesis of pharmaceuticals, and consumer health and cleaning products continues to grow, newer and better directed evolution techniques will be required to solve more complex problems. One major limitation of current directed evolution approaches is the random library used to search for improved proteins. Current technology enables average libraries on the order of 10'^8-10'^9 variants, while research has suggested that much larger libraries (>10'^13) will be necessary to discover enzymes with significantly altered specificities or entirely new functions. This proposal describes a new system in yeast that aims to overcome current limitations on library size. Aim 1 describes a method for performing in vivo mutagenesis of a target gene within the budding yeast S. cerevisiae. This method relies on the highly efficient homologous recombination machinery in yeast. Mutagenic libraries, introduced on plasmids, will be liberated using a highly specific endonuclease. The resulting linear DNA strands will target and mutagenize a gene of interest through homologous recombination. Aim 2 outlines a method for sharing mutagenic libraries between yeast to increase potential library size. By allowing two collections of yeast with complementary random libraries to mate, those two libraries can be shared among the entire population. A selective pressure will be applied, thus propagating only the best variants while essentially searching all possible mutants. Such a protocol has the potential to search very large virtual libraries well beyond the ability of existing technology. Aim 3 proposes a directed evolution experiment that uses the methods developed in Aims 1 and 2. A new variant of Cre, a site-specific recombinase widely used in mouse genetics, will be evolved using the in vivo mutagenesis and mating procedures. This experiment should convincingly demonstrate the utility of these new methods. PUBLIC HEALTH RELEVANCE: This proposal describes a new technique for directed evolution of enzymes. New enzymes generated using this technique could be used in the discovery and synthesis of new drugs or as drugs themselves. The proposed methodology could provide access to proteins with uses as varied as cleaning products, environmental remediation, and artificial organs.

描述（由申请人提供）：定向进化是一种用于产生具有新特性的蛋白质的通用方法。酶的进化已经提供了具有更高稳定性、增加的效率和改变的特异性或对映体选择性的变体。随着在工业过程、药物合成、消费者健康和清洁产品中使用酶的趋势不断增长，将需要更新和更好的定向进化技术来解决更复杂的问题。当前定向进化方法的一个主要限制是用于搜索改进蛋白质的随机文库。目前的技术使得平均文库的数量级为10 '^8 - 10'^9个变体，而研究表明，要发现具有显著改变的特异性或全新功能的酶，需要更大的文库（> 10 '^13）。该提案描述了一种新的酵母系统，旨在克服目前对文库大小的限制。目的1描述了在芽殖酵母S中进行靶基因的体内诱变的方法。啤酒。这种方法依赖于酵母中高效的同源重组机制。使用高度特异性的核酸内切酶将质粒上引入的诱变文库释放。产生的线性DNA链将通过同源重组靶向并诱变感兴趣的基因。目的2概述了一种在酵母之间共享诱变文库以增加潜在文库大小的方法。通过允许具有互补随机文库的两个酵母集合配对，这两个文库可以在整个群体中共享。将施加选择压力，从而仅繁殖最佳变体，同时基本上搜索所有可能的突变体。这样的协议有可能搜索非常大的虚拟图书馆远远超出现有技术的能力。目标3提出了一个定向进化实验，使用目标1和2中开发的方法。Cre是一种在小鼠遗传学中广泛使用的位点特异性重组酶，将通过体内诱变和交配过程进化出一种新的变体。这个实验应该令人信服地证明这些新方法的效用。公共卫生相关性：该提案描述了一种酶定向进化的新技术。使用这种技术产生的新酶可用于发现和合成新药或作为药物本身。所提出的方法可以提供获得蛋白质的各种用途，如清洁产品，环境修复和人工器官。